Strax IVS is in the process of contacting investors for an investment in the order of 3.5 M EUR (3.8 M USD), which will take the product to market.
If you are interested in receiving an investor deck, please fill in the contact form to the right.
Frode Lundsten, CEO
Central Business Registration number: DK37702579
Please complete the form below